Intelligence Profile
Research Papers
The scientific literature on BAM-15 is extremely limited, with only two published studies identified in recent years.
Molluscicidal Research (2026)
A study published in Molecules examined BAM-15's effects on the golden apple snail (Pomacea canaliculata), finding that the compound induced oxidative stress, disrupted energy metabolism, and caused tissue damage in this mollusk species. However, specific study design details and sample sizes were not provided in the available information.
Astrocyte Energy Metabolism Study (2023)
Research published in Neurochemical Research investigated energy stores in glucose-depleted rat astrocytes, though the connection to BAM-15 and specific methodological details are unclear from the available abstract information.
Clinical Trials
Only one clinical trial was identified in relation to BAM-15:
COVID-19 Immune System Study (NCT04634409)
A completed Phase 2 clinical trial examined immune system proteins in participants with mild to moderate COVID-19. However, the specific relationship between this study and BAM-15, along with participant numbers and detailed results, are not available in the provided information.
Evidence Limitations
The research base for BAM-15 appears very thin, with minimal published studies and limited clinical trial data. The available evidence does not provide sufficient detail about study methodologies, sample sizes, or clear therapeutic applications in humans. More comprehensive research would be needed to establish BAM-15's safety profile and potential clinical applications.
This information is for research purposes only and should not be considered medical advice. Consult healthcare professionals for medical guidance.